Fresh Wave Of Adalimumab Biosimilars Hits US

Multiple Humira Biosimilar Sponsors Confirm Launch, Offering Details Including Pricing

 
• By Dave Wallace

As launch dates arrive under settlement agreements with Humira originator AbbVie, multiple firms have introduced adalimumab biosimilars in the US, confirming launch and pricing details – with one biosimilar following in the footsteps of Coherus by announcing an 85% discount to the originator.

Multiple rockets and space shuttles launching from Earth into space
As many as eight adalimumab biosimilars will launch in the coming days • Source: Shutterstock

More from Products

More from Generics Bulletin